Being lazy guys , anyone keeping the dates when these trial results are due ??? Or complete ? many thanks in advance .
• Three ongoing Phase 1b trials testing CAVATAK® in combination with inmarket checkpoint inhibitors progressing well
• KEYNOTE-200 trial approaching full recruitment